Clinical Trials Directory

Trials / Conditions / Seminoma

Seminoma

17 registered clinical trials studyying Seminoma — 8 currently recruiting.

StatusTrialSponsorPhase
RecruitingPrimary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer
NCT07498959
Sahlgrenska University HospitalN/A
RecruitingTHERApy De-escalation for TESTicular Cancer
NCT06309745
Queen Mary University of London—
RecruitingRobot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer
NCT06133543
Heinrich-Heine University, DuesseldorfN/A
RecruitingPRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
NCT06144736
Heinrich-Heine University, DuesseldorfPhase 2
RecruitingDe-escalation Study for Stage IIa/IIb < 3 cm Seminoma
NCT05529251
Centre Leon BerardPhase 2
RecruitingRadiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
NCT05142982
Tata Memorial CentreN/A
Active Not RecruitingA Phase II Trial of Cabozantinib With Patients With Refractory GCTs
NCT04876456
Jennifer KingPhase 2
Active Not RecruitingA Study of miRNA 371 in Patients With Germ Cell Tumors
NCT04435756
SWOG Cancer Research Network—
Active Not RecruitingReduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
NCT03937843
Swiss Cancer InstitutePhase 2
Active Not RecruitingEvaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
NCT03158064
Memorial Sloan Kettering Cancer CenterPhase 2
Active Not RecruitingNivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
National Cancer Institute (NCI)Phase 2
RecruitingMicroRNA as Markers in Testicular Cancer
NCT04914026
Haukeland University Hospital—
Active Not RecruitingStandard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treat
NCT02375204
Alliance for Clinical Trials in OncologyPhase 3
Active Not RecruitingAdjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
NCT02341989
St. Olavs HospitalPhase 3
RecruitingTherapeutic Strategy Guided by PET-TDM for Patients With Seminoma
NCT01887340
Gustave Roussy, Cancer Campus, Grand ParisPhase 2
TerminatedTherapy De-escalation in Seminoma Stage IIA/B
NCT01593241
Swiss Cancer InstitutePhase 2
CompletedCardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients
NCT00705094
AHS Cancer Control Alberta—